I suspect Medicxi have thrown us a few coppers to help with development costs, for which we are exceedingly grateful.
And the mRNA vaccine announcement would appear to be very last minute, considering the UTS/CSIRO announcement was only last Friday (26th July).
I thought the quarterly was ok. Management are very focused on a DEP license deal and I am sure one will be announced before the end of the year. What is unknown is how much revenue it will bring in…
I suspect Medicxi have thrown us a few coppers to help with...
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.7¢ |
Change
-0.003(3.00%) |
Mkt cap ! $40.48M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 9.7¢ | $111.3K | 1.115M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 43696 | 9.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 130967 | 1 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |